In addition, DOT1L is not significantly correlated with expression of human epithelial growth factor receptor 2 (HER2) (Supplementary Fig. 3B), a biomarker for another clinically important subtype of breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.